These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
871 related items for PubMed ID: 15992636
21. Hospital policies for treatment of acute decompensated heart failure. Vats V, DiDomenico RJ, Wojtynek JE, Theobald JC, Schumock GT. Ann Pharmacother; 2007 Apr; 41(4):562-7. PubMed ID: 17374618 [Abstract] [Full Text] [Related]
22. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study. Burger AJ, Horton DP, LeJemtel T, Ghali JK, Torre G, Dennish G, Koren M, Dinerman J, Silver M, Cheng ML, Elkayam U, Prospective Randomized Evaluation of Cardiac Ectopy with Dobutamine or Natrecor Therapy. Am Heart J; 2002 Dec; 144(6):1102-8. PubMed ID: 12486437 [Abstract] [Full Text] [Related]
23. Effect of nesiritide infusion duration on renal function in acutely decompensated heart failure patients. Chow SL, Peng JT, Okamoto MP, Heywood JT. Ann Pharmacother; 2007 Apr; 41(4):556-61. PubMed ID: 17389662 [Abstract] [Full Text] [Related]
24. The benefits of early vasoactive therapy in the treatment of acute decompensated heart failure. Albert NM. J Am Acad Nurse Pract; 2005 Oct; 17(10):403-10. PubMed ID: 16181262 [Abstract] [Full Text] [Related]
25. Early intravenous heart failure therapy and outcomes among older patients hospitalized for acute decompensated heart failure: findings from the Acute Decompensated Heart Failure Registry Emergency Module (ADHERE-EM). Wong YW, Fonarow GC, Mi X, Peacock WF, Mills RM, Curtis LH, Qualls LG, Hernandez AF. Am Heart J; 2013 Aug; 166(2):349-56. PubMed ID: 23895819 [Abstract] [Full Text] [Related]
26. Effect of Inpatient Dobutamine versus Milrinone on Out-of-Hospital Mortality in Patients with Acute Decompensated Heart Failure. King JB, Shah RU, Sainski-Nguyen A, Biskupiak J, Munger MA, Bress AP. Pharmacotherapy; 2017 Jun; 37(6):662-672. PubMed ID: 28475215 [Abstract] [Full Text] [Related]
27. [Therapeutic effect of recombinant human brain natriuretic peptide for treatment of decompensated heart failure: comparison with nitroglycerin]. Xie CL, Meng SR, Wang W, Chen SM, Li P, Feng XG. Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):839-42. PubMed ID: 18504215 [Abstract] [Full Text] [Related]
28. The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure. Fonarow GC, ADHERE Scientific Advisory Committee. Rev Cardiovasc Med; 2003 May; 4 Suppl 7():S21-30. PubMed ID: 14668697 [Abstract] [Full Text] [Related]
29. Use of intravenous morphine for acute decompensated heart failure in patients with and without acute coronary syndromes. Iakobishvili Z, Cohen E, Garty M, Behar S, Shotan A, Sandach A, Gottlieb S, Mager A, Battler A, Hasdai D, Heart Failure Survey in Isarel (HFSIS) Investigators. Acute Card Care; 2011 Jun; 13(2):76-80. PubMed ID: 21627393 [Abstract] [Full Text] [Related]
30. Effect of nesiritide on renal function in patients admitted for decompensated heart failure. Arora S, Clarke K, Srinivasan V, Gradman A. QJM; 2007 Nov; 100(11):699-706. PubMed ID: 17971392 [Abstract] [Full Text] [Related]
31. Gender differences in in-hospital management and outcomes in patients with decompensated heart failure: analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). Galvao M, Kalman J, DeMarco T, Fonarow GC, Galvin C, Ghali JK, Moskowitz RM. J Card Fail; 2006 Mar; 12(2):100-7. PubMed ID: 16520256 [Abstract] [Full Text] [Related]